Focus Partners Wealth boosted its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 53.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 79,971 shares of the real estate investment trust's stock after acquiring an additional 27,689 shares during the quarter. Focus Partners Wealth's holdings in Healthpeak Properties were worth $1,617,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Parallel Advisors LLC raised its stake in shares of Healthpeak Properties by 4.2% during the first quarter. Parallel Advisors LLC now owns 13,980 shares of the real estate investment trust's stock valued at $283,000 after acquiring an additional 561 shares during the last quarter. Applied Finance Capital Management LLC lifted its stake in shares of Healthpeak Properties by 3.4% in the 1st quarter. Applied Finance Capital Management LLC now owns 17,648 shares of the real estate investment trust's stock valued at $357,000 after purchasing an additional 577 shares during the period. AssuredPartners Investment Advisors LLC raised its holdings in Healthpeak Properties by 3.1% in the first quarter. AssuredPartners Investment Advisors LLC now owns 22,088 shares of the real estate investment trust's stock worth $447,000 after purchasing an additional 666 shares in the last quarter. Banco Bilbao Vizcaya Argentaria S.A. raised its holdings in Healthpeak Properties by 4.1% in the first quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 18,146 shares of the real estate investment trust's stock worth $367,000 after purchasing an additional 722 shares in the last quarter. Finally, TCTC Holdings LLC grew its position in shares of Healthpeak Properties by 124.3% in the 1st quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust's stock worth $27,000 after buying an additional 751 shares during the period. Institutional investors own 93.57% of the company's stock.
Insider Buying and Selling
In related news, CEO Scott M. Brinker purchased 1,490 shares of the business's stock in a transaction that occurred on Monday, August 4th. The stock was bought at an average price of $16.83 per share, with a total value of $25,076.70. Following the acquisition, the chief executive officer owned 211,906 shares in the company, valued at $3,566,377.98. The trade was a 0.71% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Over the last ninety days, insiders have acquired 8,783 shares of company stock valued at $150,129. 0.23% of the stock is currently owned by insiders.
Analyst Ratings Changes
Several equities research analysts recently weighed in on DOC shares. Deutsche Bank Aktiengesellschaft reissued a "hold" rating and set a $18.00 price target (down previously from $28.00) on shares of Healthpeak Properties in a research report on Wednesday, August 20th. Scotiabank cut shares of Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and reduced their price objective for the stock from $21.00 to $19.00 in a research note on Tuesday, July 29th. Wall Street Zen cut shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Monday, July 7th. Raymond James Financial upgraded Healthpeak Properties from a "market perform" rating to an "outperform" rating and set a $20.00 price target on the stock in a report on Monday, September 15th. Finally, Robert W. Baird set a $21.00 price target on Healthpeak Properties and gave the stock an "outperform" rating in a research report on Wednesday, July 30th. Eight equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, Healthpeak Properties presently has a consensus rating of "Moderate Buy" and an average price target of $21.45.
View Our Latest Analysis on DOC
Healthpeak Properties Stock Performance
Shares of DOC traded down $0.09 during trading hours on Friday, reaching $18.48. 18,092,242 shares of the company traded hands, compared to its average volume of 5,921,982. The business has a fifty day moving average price of $17.76 and a 200-day moving average price of $18.13. Healthpeak Properties, Inc. has a 12-month low of $16.63 and a 12-month high of $23.26. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.06. The stock has a market capitalization of $12.84 billion, a P/E ratio of 77.00, a P/E/G ratio of 2.39 and a beta of 1.07.
Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, hitting the consensus estimate of $0.46. The company had revenue of $694.35 million for the quarter, compared to the consensus estimate of $697.14 million. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. Healthpeak Properties's quarterly revenue was down .2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Equities analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.
Healthpeak Properties Announces Dividend
The firm also recently declared a monthly dividend, which was paid on Friday, August 29th. Shareholders of record on Monday, August 18th were given a dividend of $0.1017 per share. The ex-dividend date was Monday, August 18th. This represents a c) dividend on an annualized basis and a yield of 6.6%. Healthpeak Properties's dividend payout ratio is currently 508.33%.
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Articles

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.